DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down SyndromeArnaud Duchon, Yann Hérault|Frontiers in Behavioral Neuroscience|2016Cited by 180
A resource of targeted mutant mouse lines for 5,061 genesMarie‐Christine Birling, Joel Schick, Skevoulla Christou et al.|Nature Genetics|2021Cited by 114
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylationMaxime Sartori, Jean‐Charles Lambert, Tiago Mendes et al.|Acta Neuropathologica|2019Cited by 76
Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down SyndromeHelin Atas-Özcan, Yann Hérault|Genes|2021Cited by 75
Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse modelsSandra Martín Lorenzo, Yann Hérault|Molecular Autism|2021Cited by 55